The FDA approved oral centanafadine (Simtriyo), a first-in-class triple reuptake inhibitor for attention deficit-hyperactivity disorder (ADHD), Otsuka announced late last week. The once-daily extended-release capsule — a norepinephrine, dopamine, and…
Dental AI company Velmeni has received 510(k) clearance from the FDA for an AI-powered 3D cone beam computed technology dental imaging software. Velmeni for Dentists 3D helps dental professionals review…
The FDA approved SimpleScreen CRC, a blood-based screening test for adults 45 years and older who are at average risk for colorectal cancer (CRC), Freenome announced. SimpleScreen CRC joins Guardant…
ISELIN, N.J.—Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of Lytenava (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, has announced…
The FDA approved a combination tablet of 325-mg acetaminophen and 110-mg naproxen sodium (Tylenol with Naproxen) for over-the-counter (OTC) pain relief, the agency announced Friday. The opioid-free combination tablet is…
VELMENI for DENTISTS® 3D brings AI-assisted CBCT segmentation, anatomical visualization, measurements, panoramic reconstruction, and workflow support to dental practices, specialists, DSOs, and imaging centers. VELMENI, a dental artificial intelligence company…
Note that some links may require registration or subscription. At least 930 people have died in Congo’s Ebola outbreak, including three dozen health workers, according to the country’s Ministry of…
The FDA approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for lowering cholesterol. Enlicitide is now approved as an adjunct to diet and exercise to reduce LDL cholesterol in…
On July 16, 2026 the FDA announced an investigation into a 5-state outbreak of Cyclospora illnesses linked to certain shredded iceberg lettuce from Mexico served at Taco Bell locations in…
The FDA approved a new starting dosage regimen for the subcutaneous formulation of lecanemab (Leqembi Iqlik) to treat adults with Alzheimer’s disease, the agency said Monday. Lecanemab is an anti-amyloid…
Compare health Insurance & supplemental plans from trusted insurance providers. Get personalized quotes in minutes and speak with a licensed agent today.
Enter your ZIP code to see plans available in your area.
